Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
267-283
Author(s):
X. Chen, S. Wang, N. Wu and C. S. Yang
Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies
Journal:
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume:
2
Page:
107-122
Author(s):
Silvia M. Sanz-Gonzalez, Antonio Cano, M. A. Valverde, Carlos Hermenegildo and Vicente Andres
Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
899-913
Author(s):
Z. Wu, I. A. M. MacPhee and D. B. G. Oliveira
Melatonin Role in Experimental Arthritis
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
1-10
Author(s):
Daniel P. Cardinali, Ana P. Garcia, Pilar Cano and Ana I. Esquifino
Recognition of Classical and Heavy Chain Forms of HLA-B27 by Leukocyte Receptors
Journal:
Current Molecular Medicine
Volume:
4
Page:
59-65
Author(s):
Rachel L. Allen and John Trowsdale
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
679-686
Author(s):
M. Thomas and W. D. Le
(Section B: Integrated Function of Drug Transporters In Vivo) Drug Transport at the Blood-Brain Barrier and the Choroid Plexus
Journal:
Current Drug Metabolism
Volume:
5
Page:
95-108
Author(s):
Candace L. Graff and Gary M. Pollack
Preface [Hot topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
iii-iii
Author(s):
Dorothea Stahl and Walter Sibrowski
Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
129-143
Author(s):
Carl Turesson
Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
203-211
Author(s):
Juan Acosta, Xuebin Qin and Jose Halperin